Telstar consolidates global supplying position
8 Feb 2013
Two years after the integration of Telstar’s activity under a single brand, the company has consolidated its position as an international supplier of global high-tech solutions for the industry linked with the life science market, especially in Europe, America and Asia.
With 50 years of experience, Telstar is now recognised as one of the ten major international suppliers of global solutions for the biopharmaceutical industry.
It is the only international specialised company with the ability to offer complete solutions in engineering, construction, process equipment design and manufacture, equipment and critical systems installation and services (commissioning and qualification, staff training and quality assurance) for turnkey bio technical and pharmaceutical plants with its own technologies, subject matter experts and resources.
Telstar, which has seven production plants and nine technology centers worldwide, invests 3% of its turnover in R&D+i.
The company is currently constructing two new pharmaceutical plants for the international Bengali company Square Pharmaceuticals and three integrated high potent lines or sterile antibiotics for the Chinese pharmceutical company Hisun Pharmaceutical.
